These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 9569197

  • 1. Monoclonal antibody-based immunoassays for the specific quantitation of rat PAI-1 antigen and activity in biological samples.
    Ngo TH, Verheyen S, Knockaert I, Declerck PJ.
    Thromb Haemost; 1998 Apr; 79(4):808-12. PubMed ID: 9569197
    [Abstract] [Full Text] [Related]

  • 2. Immunoassays for the quantitation of porcine PAI-1 antigen and activity in biological fluid samples.
    Leng HM, Brouwers E, Knockaert I, Declerck PJ.
    Thromb Haemost; 2000 Dec; 84(6):1082-6. PubMed ID: 11154117
    [Abstract] [Full Text] [Related]

  • 3. Immunological quantitation of rabbit plasminogen activator inhibitor-1 in biological samples: evidence that rabbit platelets do not contain PAI-1.
    Ngo TH, Declerck PJ.
    Thromb Haemost; 1999 Nov; 82(5):1510-5. PubMed ID: 10595646
    [Abstract] [Full Text] [Related]

  • 4. Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice.
    Declerck PJ, Verstreken M, Collen D.
    Thromb Haemost; 1995 Nov; 74(5):1305-9. PubMed ID: 8607114
    [Abstract] [Full Text] [Related]

  • 5. Characterization of recombinant rat plasminogen activator inhibitor-1 and development of immunological tools for its quantitation.
    Ngo TH, Verheyen S, Knockaert I, Declerck PJ.
    J Pharm Belg; 1997 Nov; 52(4):165-6. PubMed ID: 9316343
    [Abstract] [Full Text] [Related]

  • 6. Multicenter evaluation of commercially available methods for the immunological determination of plasminogen activator inhibitor-1 (PAI-1).
    Declerck PJ, Moreau H, Jespersen J, Gram J, Kluft C.
    Thromb Haemost; 1993 Nov 15; 70(5):858-63. PubMed ID: 8128446
    [Abstract] [Full Text] [Related]

  • 7. Expression and characterization of recombinant porcine plasminogen activator inhibitor-1.
    Bijnens AP, Knockaert I, Cousin E, Kruithof EK, Declerck PJ.
    Thromb Haemost; 1997 Feb 15; 77(2):350-6. PubMed ID: 9157595
    [Abstract] [Full Text] [Related]

  • 8. Preparation, characterization and application of monoclonal antibodies against PAI-1.
    Ding H, Wu X, Zhou X, Zhu Y, Song H.
    Chin J Biotechnol; 1994 Feb 15; 10(2):121-8. PubMed ID: 7803688
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Assay of human tissue-type plasminogen activator (t-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies to t-PA.
    Holvoet P, Cleemput H, Collen D.
    Thromb Haemost; 1985 Oct 30; 54(3):684-7. PubMed ID: 3937265
    [Abstract] [Full Text] [Related]

  • 11. Immunoreactivity of tissue plasminogen activator and of its inhibitor complexes. Biochemical and multicenter validation of a two site immunosorbent assay.
    Rånby M, Nguyen G, Scarabin PY, Samama M.
    Thromb Haemost; 1989 Jun 30; 61(3):409-14. PubMed ID: 2508254
    [Abstract] [Full Text] [Related]

  • 12. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC, Holzscheiter L, Kotzsch M, Luther T, Kiechle-Bahat M, Sweep FC, Span PN, Schmitt M, Magdolen V.
    Int J Mol Med; 2008 Feb 30; 21(2):251-9. PubMed ID: 18204793
    [Abstract] [Full Text] [Related]

  • 13. Sensitive measurement of thrombopoietin by a monoclonal antibody based sandwich enzyme-linked immunosorbent assay.
    Folman CC, von dem Borne AE, Rensink IH, Gerritsen W, van der Schoot CE, de Haas M, Aarden L.
    Thromb Haemost; 1997 Oct 30; 78(4):1262-7. PubMed ID: 9364995
    [Abstract] [Full Text] [Related]

  • 14. Enzyme-linked immunosorbent assay of total inhibin: direct determination based on inhibin alpha subunit-specific monoclonal antibodies.
    Khosravi J, Krishna RG, Khaja N, Bodani U, Diamandi A.
    Clin Biochem; 2004 May 30; 37(5):370-6. PubMed ID: 15087252
    [Abstract] [Full Text] [Related]

  • 15. Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies.
    Welfringer F, d'Athis P, Scherrmann JM, Hervé F.
    J Immunol Methods; 2005 Dec 20; 307(1-2):82-95. PubMed ID: 16305797
    [Abstract] [Full Text] [Related]

  • 16. S35225 is a direct inhibitor of Plasminogen Activator Inhibitor type-1 activity in the blood.
    Rupin A, Gaertner R, Mennecier P, Richard I, Benoist A, De Nanteuil G, Verbeuren TJ.
    Thromb Res; 2008 Dec 20; 122(2):265-70. PubMed ID: 18177924
    [Abstract] [Full Text] [Related]

  • 17. Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.
    Grebenchtchikov N, Maguire TM, Riisbro R, Geurts-Moespot A, O'Donovan N, Schmitt M, McGreal G, McDermott E, O'Higgins N, Brünner N, Sweep CG, Duffy MJ.
    Oncol Rep; 2005 Jul 20; 14(1):235-9. PubMed ID: 15944795
    [Abstract] [Full Text] [Related]

  • 18. Phosphorothioate oligodeoxyribonucleotides antisense to PAI-1 mRNA increase fibrinolysis and modify experimental thrombosis in rats.
    Pawlowska Z, Pluskota E, Chabielska E, Buczko W, Okruszek A, Stec WJ, Cierniewski CS.
    Thromb Haemost; 1998 Feb 20; 79(2):348-53. PubMed ID: 9493589
    [Abstract] [Full Text] [Related]

  • 19. Elucidation of the binding regions of PAI-1 neutralizing antibodies using chimeric variants of human and rat PAI-1.
    Bijnens AP, Ngo TH, Gils A, Dewaele J, Knockaert I, Stassen JM, Declerck PJ.
    Thromb Haemost; 2001 May 20; 85(5):866-74. PubMed ID: 11372681
    [Abstract] [Full Text] [Related]

  • 20. Prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in cytosols and pellet extracts derived from 892 breast cancer patients.
    de Witte JH, Sweep CG, Klijn JG, Grebenschikov N, Peters HA, Look MP, van Tienoven TH, Heuvel JJ, van Putten WL, Benraad TJ, Foekens JA.
    Br J Cancer; 1999 Mar 20; 79(7-8):1190-8. PubMed ID: 10098758
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.